The largest study to correlate genetics with response to cancer drugs releases its first results today. The researchers behind the study, based at the MGH Cancer Center and the Wellcome Trust Sanger Institute, describe the responses of 350 cancer samples to 18 anticancer therapeutics.

Largest study of genomes and cancer treatments releases first results

UK–US collaboration building up a database for personalized cancer treatment

15/Jul/2010

The largest study to correlate genetics with response to cancer drugs releases its first results today. The researchers behind the study, based at Massachusetts General Hospital Cancer Center and the Wellcome Trust Sanger Institute, describe in this initial dataset the responses of 350 cancer samples to 18 anticancer therapeutics.

These first results, made freely available on the Genomics of Drug Sensitivity website, will help cancer researchers around the world to seek better understanding of cancer genetics and could help to improve treatment regimens.

Link to full Wellcome Trust Sanger Institute news release.

Media Contacts: Katie Marquedant, 617 726-0337, kmarquedant@partner.org